Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $40.1200 (-2.22%) ($40.1200 - $40.1200) on Tue. Jan. 4, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.58% (three month average) | RSI | 76 | Latest Price | $40.1200(-2.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 4.4% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(53%) IWO(49%) IWM(47%) IWC(44%) IWN(44%) | Factors Impacting HALO price | HALO will decline at least -1.29% in a week (0% probabilities). VIXM(-27%) UUP(-12%) VXX(-9%) TBT(-3%) GLD(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.29% (StdDev 2.58%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $40.38(-0.64%) | 10 Day Moving Average | $40.15(-0.07%) | 20 Day Moving Average | $37.77(6.22%) | To recent high | -2.2% | To recent low | 26.1% | Market Cap | $5.483b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |